Skip to Main Content
Table 3

Survival analyses for gender

GroupPemetrexed + cisplatin survival, median (mo)Cisplatin alone survival, median (mo)P (log rank)
Female randomized and treated (n = 83) 15.7 7.5 0.012 
Female fully folic acid/vitamin B12 supplemented (n = 61) 18.9 7.4 0.01 
Male randomized and treated (n = 365) 11 9.4 0.176 
Male fully folic acid/vitamin B12supplemented (n = 270) 12.8 10.4 0.388 
GroupPemetrexed + cisplatin survival, median (mo)Cisplatin alone survival, median (mo)P (log rank)
Female randomized and treated (n = 83) 15.7 7.5 0.012 
Female fully folic acid/vitamin B12 supplemented (n = 61) 18.9 7.4 0.01 
Male randomized and treated (n = 365) 11 9.4 0.176 
Male fully folic acid/vitamin B12supplemented (n = 270) 12.8 10.4 0.388 
Close Modal

or Create an Account

Close Modal
Close Modal